|
|
|
40
|
49712
|
APO-HYDROXYUREA 500MG CAP (APO/COL)
|
HYDROXYUREA
|
APO-HYDROXYUREA
|
100'S
|
C
|
93.70
|
0.94
|
CAPSULE
|
0
|
CAP
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
49712
|
APO-HYDROXYUREA 500MG CAP (APO)
|
HYDROXYUREA
|
APO-HYDROXYUREA
|
100'S
|
C
|
46.21
|
0.46
|
CAP
|
150
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4971J
|
HYDROXYUREA 500MG CAP (SLS/AHI)
|
HYDROXYUREA
|
HYDROXYUREA
|
100'S
|
A
|
33.30
|
0.33
|
CAPSULE
|
150
|
CAP
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4971N
|
HYDROXYUREA 500MG CAP (FSB)
|
HYDROXYUREA
|
HYDROXYUREA
|
100'S
|
A
|
25.14
|
0.2514
|
CAP
|
150
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4971X
|
ZYDROX 500MG CAP (ZUV) HYDROXYUREA
|
HYDROXYUREA
|
ZYDROX
|
100'S
|
A
|
25.12
|
0.2512
|
CAP
|
150
|
BOX
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4971X
|
ZYDROX 500MG CAP (ZUV) HYDROXYUREA
|
HYDROXYUREA
|
ZYDROX
|
100'S
|
A
|
19.38
|
0.19
|
CAP
|
150
|
BLIS
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4971Z
|
HYDROFORD 500MG CAP (JLP) HYDROXYUREA
|
HYDROXYUREA
|
HYDROFORD
|
100'S
|
A
|
17.94
|
0.18
|
CAP
|
150
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|